Dendritic cells are central to the development of immunity, as they are specialized in initiating antigen-specific immune responses. In this review, we briefly present the existing knowledge on dendritic cell biology and how their division in different dendritic cell subsets may impact the development of immune responses. In addition, we explore the use of chimeric monoclonal antibodies that bind to dendritic cell surface receptors, with an emphasis on the C-type lectin family of endocytic receptors, to deliver antigens directly to these cells. Promising preclinical studies have shown that it is possible to modulate the development of immune responses to different pathogens when monoclonal antibodies fused to pathogen-derived antigens are used to deliver the antigen to different subsets of dendritic cells. This approach can be used to improve the efficacy of vaccines against different pathogens.
MellmanISteinmanRM.Dendritic cells: specialized and regulated antigen processing machines.Cell2001;106:255–8
2.
GuermonprezPValladeauJZitvogelLThéryCAmigorenaS.Antigen presentation and T cell stimulation by dendritic cells.Annu Rev Immunol2002;20:621–67
3.
MacLennanIVinuesaC.Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses.Immunity2002;17:235–8
4.
HawigerDInabaKDorsettYGuoMMahnkeKRiveraMRavetchJVSteinmanRMNussenzweigMC.Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo.J Exp Med2001;194:769–79
5.
YamazakiSDudziakDHeidkampGFFioreseCBonitoAJInabaKNussenzweigMCSteinmanRM.CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.J Immunol2008;181:6923–33
6.
YinXChenSEisenbarthSC.Dendritic cell regulation of T helper cells.Annu Rev Immunol2021;39:759–90
7.
SwieckiMColonnaM.The multifaceted biology of plasmacytoid dendritic cells.Nat Rev Immunol2015;15:471–85
8.
SchlitzerAMcGovernNTeoPZelanteTAtarashiKLowDHoAWSeePShinAWasanPSHoeffelGMalleretBHeisekeAChewSJardineLPurvisHAHilkensCMTamJPoidingerMStanleyERKrugABReniaLSivasankarBNgLGCollinMRicciardi-CastagnoliPHondaKHaniffaMGinhouxF.IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses.Immunity2013;38:970–83
9.
ShinCHanJAChoiBChoYKDoYRyuS.Intrinsic features of the CD8α(-) dendritic cell subset in inducing functional T follicular helper cells.Immunol Lett2016;172:21–8
HovavAH.Dendritic cells of the oral mucosa.Mucosal Immunol2014;7:27–37
14.
PlattCDMaJKChalouniCEbersoldMBou-ReslanHCaranoRAMellmanIDelamarreL.Mature dendritic cells use endocytic receptors to capture and present antigens.Proc Natl Acad Sci U S A2010;107:4287–92
15.
MeradMSathePHelftJMillerJMorthaA.The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.Annu Rev Immunol2013;31:563–604
16.
DornerBGDornerMBZhouXOpitzCMoraAGuttlerSHutloffAMagesHWRankeKSchaeferMJackRSHennVKroczekRA.Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells.Immunity2009;31:823–33
17.
CrowleyMInabaKWitmer-PackMSteinmanRM.The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus.Cell Immunol1989;118:108–25
18.
DudziakDKamphorstAOHeidkampGFBuchholzVRTrumpfhellerCYamazakiSCheongCLiuKLeeHWParkCGSteinmanRMNussenzweigMC.Differential antigen processing by dendritic cell subsets in vivo.Science2007;315:107–11
19.
JiangWSwiggardWJHeuflerCPengMMirzaASteinmanRMNussenzweigMC.The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing.Nature1995;375:151–5
20.
CarterRWThompsonCReidDMWongSYToughDF.Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1.J Immunol2006;177:2276–84
21.
MacriCDumontCJohnstonAPMinternJD.Targeting dendritic cells: a promising strategy to improve vaccine effectiveness.Clin Transl Immunology2016;5:e66
22.
CarayanniotisGBarberBH.Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC.Nature1987;327:59–61
23.
FrletaDDemianDWadeWF.Class II-targeted antigen is superior to CD40-targeted antigen at stimulating humoral responses in vivo.Int Immunopharmacol2001;1:265–75
24.
SerreKMachyPGrivelJCJollyGBrunNBarbetJLesermanL.Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells.J Immunol1998;161:6059–67
25.
SniderDPSegalDM.Targeted antigen presentation using crosslinked antibody heteroaggregates.J Immunol1987;139:1609–16
26.
CastroFVTuttALWhiteALTeelingJLJamesSFrenchRRGlennieMJ.CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses.Eur J Immunol2008;38:2263–73
27.
WhiteALTuttALJamesSWilkinsonKACastroFVDixonSVHitchcockJKhanMAl-ShamkhaniACunninghamAFGlennieMJ.Ligation of CD11c during vaccination promotes germinal centre induction and robust humoral responses without adjuvant.Immunology2010;131:141–51
28.
FossumEGrødelandGTerhorstDTveitaAAVikseEMjaalandSHenriSMalissenBBogenB.Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.Eur J Immunol2015;45:624–35
29.
KastenmullerWKastenmullerKKurtsCSederRA.Dendritic cell-targeted vaccines—hope or hype?Nat Rev Immunol2014;14:705–11
30.
BonifazLBonnyayDMahnkeKRiveraMNussenzweigMCSteinmanRM.Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.J Exp Med2002;196:1627–38
31.
BonifazLCBonnyayDPCharalambousADargusteDIFujiiSSoaresHBrimnesMKMoltedoBMoranTMSteinmanRM.In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination.J Exp Med2004;199:815–24
32.
BoscardinSBHafallaJCMasilamaniRFKamphorstAOZebroskiHARaiUMorrotAZavalaFSteinmanRMNussenzweigRSNussenzweigMC.Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses.J Exp Med2006;203:599–606
33.
GinhouxFGuilliamsMNaikSH.Editorial: dendritic cell and macrophage nomenclature and classification.Front Immunol2016;7:168
34.
CaminschiIProiettoAIAhmetFKitsoulisSShin TehJLoJCRizzitelliAWuLVremecDvan DommelenSLCampbellIKMaraskovskyEBraleyHDaveyGMMottramPvan de VeldeNJensenKLewAMWrightMDHeathWRShortmanKLahoudMH.The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement.Blood2008;112:3264–73
35.
LiJAhmetFSullivanLCBrooksAGKentSJDe RoseRSalazarAMReiseSousaCShortmanKLahoudMHHeathWRCaminschiI.Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates.Eur J Immunol2015;45:854–64
36.
SanchoDMourão-SáDJoffreOPSchulzORogersNCPenningtonDJCarlyleJRReiseSousaC.Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin.J Clin Invest2008;118:2098–110
37.
JoffreOPSanchoDZelenaySKellerAMReiseSousaC.Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A.Eur J Immunol2010;40:1255–65
38.
LahoudMHAhmetFKitsoulisSWanSSVremecDLeeCNPhipsonBShiWSmythGKLewAMKatoYMuellerSNDaveyGMHeathWRShortmanKCaminschiI.Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype.J Immunol2011;187:842–50
39.
LahoudMHProiettoAIAhmetFKitsoulisSEidsmoLWuLSathePPieterszSChangHWWalkerIDMaraskovskyEBraleyHLewAMWrightMDHeathWRShortmanKCaminschiI.The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses.J Immunol2009;182:7587–94
40.
AhlénGStrindeliusLJohanssonTNilssonAChatzissavidouNSjöblomMRovaUHolgerssonJ.Mannosylated mucin-type immunoglobulin fusion proteins enhance antigen-specific antibody and T lymphocyte responses.PLoS ONE2012;7:e46959
41.
TewariKFlynnBJBoscardinSBKastenmuellerKSalazarAMAndersonCASoundarapandianVAhumadaAKelerTHoffmanSLNussenzweigMCSteinmanRMSederRA.Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.Vaccine2010;28:7256–66
42.
AmorimKNRampazoEVAntonialliRYamamotoMMRodriguesMMSoaresISBoscardinSB.The presence of T cell epitopes is important for induction of antibody responses against antigens directed to DEC205(+) dendritic cells.Sci Rep2016;6:39250
43.
AntonialliRSulczewskiFBAmorimKAlmeidaBDSFerreiraNSYamamotoMMSoaresISFerreiraLCSRosaDSBoscardinSB.CpG oligodeoxinucleotides and flagellin modulate the immune response to antigens targeted to CD8α(+) and CD8α(-) conventional dendritic cell subsets.Front Immunol2017;8:1727
44.
SulczewskiFBMartinoLAAlmeidaBDSZanetiABFerreiraNSAmorimKNDSYamamotoMMApostolicoJSRosaDSBoscardinSB.Conventional type 1 dendritic cells induce TH 1, TH 1-like follicular helper T cells and regulatory T cells after antigen boost via DEC205 receptor.Eur J Immunol2020;50:1895–911
45.
SulczewskiFBMartinoLASallesDYamamotoMMRosaDSBoscardinSB.STAT3 signaling modulates the immune response induced after antigen targeting to conventional type 1 dendritic cells through the DEC205 receptor.Front Immunol2022;13:1006996
46.
SulczewskiFBMartinoLAda Silva AlmeidaBYamamotoMMRosaDSBoscardinSB.STAT6 signaling pathway controls germinal center responses promoted after antigen targeting to conventional type 2 dendritic cells.Curr Res Immunol2021;2:120–31
47.
MatosIMizeninaOLubkinASteinmanRMIdoyagaJ.Targeting antigens to dendritic cells in vivo induces protective immunity.PLoS ONE2013;8:e67453
48.
RampazoEVAmorimKNYamamotoMMPanatieriRHRodriguesMMBoscardinSB.Antigen targeting to dendritic cells allows the identification of a CD4 T-cell epitope within an immunodominant trypanosoma cruzi antigen.PLoS ONE2015;10:e0117778
49.
LakhrifZMoreauAHéraultBDi-TommasoAJusteMMoiréNDimier-PoissonIMévélecMNAubreyN.Targeted delivery of toxoplasma gondii antigens to dendritic cells promote immunogenicity and protective efficiency against toxoplasmosis.Front Immunol2018;9:317
50.
TrumpfhellerCFinkeJSLopezCBMoranTMMoltedoBSoaresHHuangYSchlesingerSJParkCGNussenzweigMCGranelli-PipernoASteinmanRM.Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.J Exp Med2006;203:607–17
51.
LonghiMPTrumpfhellerCIdoyagaJCaskeyMMatosIKlugerCSalazarAMColonnaMSteinmanRM.Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant.J Exp Med2009;206:1589–602
52.
TrumpfhellerCCaskeyMNchindaGLonghiMPMizeninaOHuangYSchlesingerSJColonnaMSteinmanRM.The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine.Proc Natl Acad Sci U S A2008;105:2574–9
53.
NguLNNjiNNAmbadaGNgohAANjambe PrisoGDTchadjiJCLissomAMagagoumSHSakeCNTchouangueuTFChukwumaGOOkoliASSagniaBChukwuanukwuRTebitDMEsimoneCOWaffoABParkCGÜberlaKNchindaGW.Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8(+) T cells.Immun Inflamm Dis2018;6:163–75
54.
NchindaGKuroiwaJOksMTrumpfhellerCParkCGHuangYHannamanDSchlesingerSJMizeninaONussenzweigMCUberlaKSteinmanRM.The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells.J Clin Invest2008;118:1427–36
55.
IdoyagaJLubkinAFioreseCLahoudMHCaminschiIHuangYRodriguezAClausenBEParkCGTrumpfhellerCSteinmanRM.Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to langerin, DEC205, and Clec9A.Proc Natl Acad Sci U S A2011;108:2384–9
56.
FonsecaSGCoutinho-SilvaAFonsecaLASeguradoACMoraesSLRodriguesHHammerJKallasEGSidneyJSetteAKalilJCunha-NetoE.Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients.AIDS2006;20:2263–73
57.
ApostólicoJSLunardelliVAYamamotoMMSouzaHFCunha-NetoEBoscardinSBRosaDS.Dendritic cell targeting effectively boosts T cell responses elicited by an HIV multiepitope DNA vaccine.Front Immunol2017;8:101
58.
HenriquesHRRampazoEVGonçalvesAJVicentinECAmorimJHPanatieriRHAmorimKNYamamotoMMFerreiraLCAlvesAMBoscardinSB.Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge.PLoS Negl Trop Dis2013;7:e2330
59.
ZanetiABYamamotoMMSulczewskiFBAlmeidaBDSSouzaHFSFerreiraNSMaedaDLNFSalesNSRosaDSFerreiraLCSBoscardinSB.Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4(+) T cells to the dengue virus envelope protein domain III.Front Immunol2019;10:59
60.
DoYKohHParkCGDudziakDSeoPMehandruSChoiJHCheongCParkSPerlinDSPowellBSSteinmanRM.Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague.Eur J Immunol2010;40:2791–6
61.
ChenBYZhouGLiQLLuJSShiDYPangXBZhouXWYuYZHuangPT.Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells.Immunol Lett2017;190:118–24
62.
CharalambousAOksMNchindaGYamazakiSSteinmanRM.Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin.J Immunol2006;177:8410–21
63.
WangBZaidiNHeLZZhangLKuroiwaJMKelerTSteinmanRM.Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.Breast Cancer Res2012;14:R39
64.
NeubertKLehmannCHHegerLBaranskaAStaedtlerAMBuchholzVRYamazakiSHeidkampGFEissingNZebroskiHNussenzweigMCNimmerjahnFDudziakD.Antigen delivery to CD11c+CD8- dendritic cells induces protective immune responses against experimental melanoma in mice in vivo.J Immunol2014;192:5830–8
65.
SilvaMOAlmeidaBSSalesNSDinizMOApsLRMMRodriguesKBSilvaJRMorenoACRPorchiaBFMMSulczewskiFBBoscardinSBFerreiraLCS. Antigen delivery to DEC205(+) dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites.Int J Biol Sci2021;17:2944–56
66.
JungbluthAAChenYTStockertEBusamKJKolbDIversenKCoplanKWilliamsonBAltorkiNOldLJ.Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues.Int J Cancer2001;92:856–60
67.
TsujiTMatsuzakiJKellyMPRamakrishnaVVitaleLHeLZKelerTOdunsiKOldLJRitterGGnjaticS.Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.J Immunol2011;186:1218–27
68.
DhodapkarMVSznolMZhaoBWangDCarvajalRDKeohanMLChuangESanbornRELutzkyJPowderlyJKlugerHTejwaniSGreenJRamakrishnaVCrockerAVitaleLYellinMDavisTKelerT.Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205.Sci Transl Med2014;6:232ra51
69.
GriffithsEASrivastavaPMatsuzakiJBrumbergerZWangESKocentJMillerARoloffGWWongHYPaluchBELutgen-DunckleyLGMartensBLOdunsiKKarpfARHouriganCSNemethMJ.NY-ESO-1 vaccination in combination with decitabine induces antigen-specific T-lymphocyte responses in patients with myelodysplastic syndrome.Clin Cancer Res2018;24:1019–29
70.
BhardwajNFriedlanderPAPavlickACErnstoffMSGastmanBRHanksBACurtiBDAlbertiniMRLukeJJBlazquezABBalanSBedognettiDBeechemJMCrockerASD’AmicoLDanaherPDavisTAHawthorneTHessBWKelerTLundgrenLMorishimaCRamchurrenNRinchaiDSalazarAMSalimBASharonEVitaleLAWangEWarrenSYellinMJDisisMLCheeverMAFlingSP.Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets.Nat Cancer2020;1:1204–17
